BIA Investor Breakfast - Future of the UK: Industrial Strategy and Patient Capital Review
BIA and our hosts Stifel invite you to join them for an informal networking breakfast and special panel event to discuss the Patient Capital Review and other factors that will impact the growth of the UK biotech sector in the coming years.
We’ll be joined by ex-science and Treasury minister, Lord David Willetts to give his personal insight and experience, alongside other experts on the sector.
Open to investors, fund managers and brokers ONLY
08.00 - 08.50 Registration and networking breakfast
08:50 - 09.00 Welcome
09.00 - 09.10 Review of BIA/Informa Q2 Finance Report
Max Herrmann, Managing Director, Stifel
09.10 - 09.25 Brexit and the future of regulation
Steve Bates OBE, Chief Executive Officer, BIA
09.25 - 9.45 The future of the UK - Industrial Strategy and Patient Capital Review
Panel:
Steve Bates, OBE, Chief Executive Officer, BIA
Kym Denny, Chief Executive Officer, hVIVO
Max Herrmann, Managing Director, Stifel
Lord David Willetts
09.45 - 10.00 Q&A
10.00 - 10.30 Refreshments and networking
10.30 Close
Stifel
150 Cheapside
London
EC2V 6ET